Investment accelerates U.S. rollout of a scalable, at-home brain neuromodulation therapy for patients with depression and inadequate response to at least one antidepressant CORAL SPRINGS, Fla., March ...
Soin Neuroscience, a Dayton, Ohio-based medical device innovator founded by pain management physician Amol Soin, M.D., today announced the sale of a portfolio of intellectual property related to ...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
Medical Device Network on MSN
FDA clears Bioness Medical’s neuromodulation system for stroke rehabilitation
Bioness’s PoNS system is designed to improve gait impairment in stroke patients by stimulating the trigeminal and facial cranial nerves.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...
In an article published in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results